Management

Director of the Center:

Prof Bernard Lerer

Prof. Bernard Lerer:
Bernard is Professor of Psychiatry; Founder, Biological Psychiatry Laboratory; Hadassah – Hebrew University Medical Center. Prof. Lerer completed medical school at the University of Cape Town, clinical training in psychiatry at Hadassah and Herzog Hospitals and a post-doctoral fellowship in biological psychiatry and psychopharmacology at Lafayette Clinic – Wayne State University, Detroit. He has served as Director of the National Institute for Psychobiology in Israel and was Founding Editor-in-Chief of the International Journal of Neuropsychopharmacology He has received the A.E. Bennet Award of the US Society for Biological Psychiatry, the Mentorship Award of the Israel Society for Biological Psychiatry and the Lifetime Achievement Awards of the Israel Psychiatric Association and the International Society for Affective Disorders. He is a Fellow of the American College of Neuropsychopharmacology. Prof. Lerer’s research expertise is in behavioral and biochemical psychopharmacology, molecular neurobiology and neurogenetics. He has extensive international research collaborations. He has received research support from NIH, the European Union, the Israel Science Foundation and the Israel Ministries of Health, Science and Economics. Prof. Lerer has been granted several patients and has published over 380 papers in peer reviewed journals and 4 books.

Director of the Center:

Hanna Rosenmann 2

Prof. Hanna Rosenmann:

Hanna is Associate Professor of Neurobiology, at The Hebrew University Hadassah Medical School, Jerusalem.  She has received her doctorate in Neurogenetics from the Hebrew University (HU), followed by post-doc studies in the field of Neurobiology in the HU. Her scientific research, in the Laboratory of Experimental Neurology, Department of Neurology, Hadassah Hebrew University Medical Center, focuses mainly on Alzheimer’s disease, tauopathies and neurodegeneration, developing novel animal models using genetic, autoimmune and genetic/environmental interactive approaches. The novel tangle-tg mouse model generated in her lab is used for developing anti-tangle therapeutic approaches, particularly in her pioneering studies on phos-tau immunotherapy, which provided the basis for the development of efficient and safe anti-tangle vaccination. Her novel tangle-model is also in use by various leading research groups in this field. Hanna also developed the novel therapeutic approach of CSF Exchange Therapy for neurodegenerative diseases, and her group develops also mitochondrial transfer therapy for Alzheimer’s disease.   She has published numerous papers in the field of neuroscience, and serves on the editorial board of several neuroscience journals.

Associate Director of the Center:

Tamir Ben Hur

Prof. Tamir Ben Hur:

Tamir Ben-Hur is Professor of Neurology and holds the Israel S. Wechsler Chair in Neurology at The Hebrew University Hadassah Medical School. He earned his M.D. and Ph.D. degrees (in Virology) from the Hebrew University, trained in Neurology at Hadassah University Hospital and conducted post-doctoral studies at The Pasteur Institute in Paris. He has served several roles in the Faculty of Medicine and the Israel Society of Neurology. He is Chairman of the Division of Clinical Neurosciences at Hadassah – Hebrew University Medical Center. His clinical interests are in general Neurology, and Neuro-immunology. His scientific research focuses mainly on the therapeutic properties of stem cells, and their bilateral interactions with the nervous system in normal and pathologic states. His pioneering research laid the scientific basis for current use of stem cells in multiple sclerosis. He has published numerous papers in basic and clinical neurosciences, and serves on the editorial board of several neuroscience journals.